A new design for bispecific antibodies enables efficient production of stable molecules with good pharmacodynamic properties.
Access options
Subscribe to Journal
Get full journal access for 1 year
$259.00
only $21.58 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
from$8.99
All prices are NET prices.

References
- 1
Wu, C.Y.H., Grinnell, C. & Bryant, S. Nat. Biotechnol. 25, 1290–1297 (2007).
- 2
Milstein, C. & Cuello, A.C. Nature 305, 537–540 (1983).
- 3
Carter, P. J. Immunol. Methods 248, 7–15 (2001).
- 4
Holliger, P., Prospero, T. & Winter, G. Proc. Natl. Acad. Sci. USA 90, 6444–6448 (1993).
- 5
Pack, P., Muller, K., Zahn, R. & Pluckthun, A. J. Mol. Biol. 246, 28–34 (1995).
- 6
Pack, P. & Pluckthun, A. Biochemistry 31, 1579–1584 (1992).
- 7
Natsume, A. et al. J. Biochem. 140, 359–368 (2006).
Author information
Affiliations
Rights and permissions
About this article
Cite this article
Morrison, S. Two heads are better than one. Nat Biotechnol 25, 1233–1234 (2007). https://doi.org/10.1038/nbt1107-1233
Issue Date:
Further reading
-
Bispecific monoclonal antibodies for targeted immunotherapy of solid tumors: Recent advances and clinical trials
International Journal of Biological Macromolecules (2021)
-
Selection for Anti-transferrin Receptor Bispecific T-cell Engager in Different Molecular Formats
Current Medical Science (2020)
-
IL-20 in rheumatoid arthritis
Drug Discovery Today (2017)
-
Flaxseed extract exhibits mucosal protective effect in acetic acid induced colitis in mice by modulating cytokines, antioxidant and antiinflammatory mechanisms
International Immunopharmacology (2016)
-
How will new and future therapies change our treatment of IBD?
Expert Review of Clinical Immunology (2016)